{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:54:18Z","timestamp":1790171658945,"version":"4.1.0"},"reference-count":45,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,5,3]]},"DOI":"10.3233\/jad-161265","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T11:45:01Z","timestamp":1491565501000},"page":"203-214","source":"Crossref","is-referenced-by-count":49,"title":["Angiotensin-III is Increased in Alzheimer\u2019s Disease in Association with Amyloid-\u03b2 and Tau Pathology"],"prefix":"10.1177","volume":"58","author":[{"given":"Patrick Gavin","family":"Kehoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Hibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Scott","family":"Miners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-161265_ref1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00109-008-0331-5","article-title":"Brain renin angiotensin in disease","volume":"86","author":"Phillips","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"10.3233\/JAD-161265_ref2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2011.07.001","article-title":"Brain renin-angiotensin\u2013a new look at an old system","volume":"95","author":"Wright","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-161265_ref3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00424-012-1102-2","article-title":"The brain renin-angiotensin system: A diversity of functions and implications for CNS diseases","volume":"465","author":"Wright","year":"2013","journal-title":"Pflugers Arch"},{"key":"10.3233\/JAD-161265_ref4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fendo.2013.00158","article-title":"A Role for the Brain RAS in Alzheimer\u2019s and Parkinson\u2019s Diseases","volume":"4","author":"Wright","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.3233\/JAD-161265_ref5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tins.2009.07.006","article-title":"Angiotensins in Alzheimer\u2019s disease - friend or foe?","volume":"32","author":"Kehoe","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-161265_ref6","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1016\/j.febslet.2012.09.004","article-title":"Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains","volume":"586","author":"Tian","year":"2012","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-161265_ref7","doi-asserted-by":"crossref","first-page":"e16037","DOI":"10.1371\/journal.pone.0016037","article-title":"Central angiotensin II stimulation promotes beta amyloid production in Sprague Dawley rats","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-161265_ref8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2990.2007.00885.x","article-title":"Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer\u2019s disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy","volume":"34","author":"Miners","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-161265_ref9","first-page":"163","article-title":"Angiotensin-converting enzyme levels and activity in Alzheimer\u2019s disease: Differences in brain and CSF ACE and association with ACE1 genotypes","volume":"1","author":"Miners","year":"2009","journal-title":"Am J Transl Res"},{"key":"10.3233\/JAD-161265_ref10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1517\/13543784.2013.812631","article-title":"Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer\u2019s disease","volume":"22","author":"Ashby","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.3233\/JAD-161265_ref11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrd3869","article-title":"Drug repositioning for Alzheimer\u2019s disease","volume":"11","author":"Corbett","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-161265_ref12","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/jm00044a016","article-title":"Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols","volume":"37","author":"Chauvel","year":"1994","journal-title":"J Med Chem"},{"key":"10.3233\/JAD-161265_ref13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-8993(93)90997-2","article-title":"Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II","volume":"606","author":"Healy","year":"1993","journal-title":"Brain Res"},{"key":"10.3233\/JAD-161265_ref14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0006-8993(90)91595-8","article-title":"Mn2(+)-activated aspartate aminopeptidase activity, subcellular localization in young and adult rat brain","volume":"522","author":"Ramirez","year":"1990","journal-title":"Brain Res"},{"key":"10.3233\/JAD-161265_ref15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/jm00370a001","article-title":"Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes","volume":"27","author":"Rich","year":"1984","journal-title":"J Med Chem"},{"key":"10.3233\/JAD-161265_ref16","doi-asserted-by":"crossref","first-page":"24539","DOI":"10.1016\/S0021-9258(19)74498-6","article-title":"Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors","volume":"268","author":"Mukoyama","year":"1993","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-161265_ref17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/351233a0","article-title":"Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor","volume":"351","author":"Murphy","year":"1991","journal-title":"Nature"},{"key":"10.3233\/JAD-161265_ref18","first-page":"957","article-title":"Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin","volume":"242","author":"Abhold","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-161265_ref19","first-page":"R1551","article-title":"Structure-function analyses of brain angiotensin control of pressor action in rats","volume":"257","author":"Wright","year":"1989","journal-title":"Am J Physiol"},{"key":"10.3233\/JAD-161265_ref20","first-page":"R514","article-title":"Pressor action and dipsogenicity induced by angiotensin II and III in rats","volume":"249","author":"Wright","year":"1985","journal-title":"Am J Physiol"},{"key":"10.3233\/JAD-161265_ref21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0006-8993(85)90988-6","article-title":"Brain angiotensin II and III binding and dipsogenicity in the rabbit","volume":"358","author":"Wright","year":"1985","journal-title":"Brain Res"},{"key":"10.3233\/JAD-161265_ref22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.ph.49.030187.002213","article-title":"Functions of angiotensin in the central nervous system","volume":"49","author":"Phillips","year":"1987","journal-title":"Annu Rev Physiol"},{"key":"10.3233\/JAD-161265_ref23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/edrv-13-2-329","article-title":"Brain and pituitary angiotensin","volume":"13","author":"Saavedra","year":"1992","journal-title":"Endocr Rev"},{"key":"10.3233\/JAD-161265_ref24","doi-asserted-by":"crossref","first-page":"11968","DOI":"10.1073\/pnas.93.21.11968","article-title":"Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: Predominant role of angiotensin III in the control of vasopressin release","volume":"93","author":"Zini","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-161265_ref25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/CS20130396","article-title":"A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors","volume":"127","author":"Gao","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"10.3233\/JAD-161265_ref26","first-page":"217","article-title":"Orally active aminopeptidase A inhibitors reduce blood pressure: A new strategy for treating hypertension","volume":"208","author":"Llorens-Cortes","year":"2014","journal-title":"Biol Aujourdhui"},{"key":"10.3233\/JAD-161265_ref27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/HYPERTENSIONAHA.112.190942","article-title":"Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats","volume":"60","author":"Marc","year":"2012","journal-title":"Hypertension"},{"key":"10.3233\/JAD-161265_ref28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2011.06.006","article-title":"The role of the brain renin-angiotensin system in hypertension: Implications for new treatment","volume":"95","author":"Marc","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-161265_ref29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-2952(89)90165-2","article-title":"Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M","volume":"38","author":"Palmieri","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-161265_ref30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1476-5381.2011.01402.x","article-title":"Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers","volume":"164","author":"Albiston","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-161265_ref31","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1096\/fj.08-112227","article-title":"Identification andcharacterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase","volume":"22","author":"Albiston","year":"2008","journal-title":"FASEB J"},{"key":"10.3233\/JAD-161265_ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2017.01.006","article-title":"Changes of renin-angiotensin system-related aminopeptidases in early stage Alzheimer\u2019s disease","volume":"89","author":"Gard","year":"2017","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-161265_ref33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.exger.2013.03.002","article-title":"Plasma renin-angiotensin system-regulating aminopeptidase activities are modified in early stage Alzheimer\u2019s disease and show gender differences but are not related to apolipoprotein E genotype","volume":"48","author":"Puertas Mdel","year":"2013","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-161265_ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-161265_ref35","first-page":"73","article-title":"ACE variants and association with brain Abeta levels in Alzheimer\u2019s disease","volume":"3","author":"Miners","year":"2010","journal-title":"Am J Transl Res"},{"key":"10.3233\/JAD-161265_ref36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1750-3639.2010.00374.x","article-title":"Higher soluble amyloid beta concentration in frontal cortex of young adults than in normal elderly or Alzheimer\u2019s disease","volume":"20","author":"van Helmond","year":"2010","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-161265_ref37","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1212\/01.wnl.0000261920.03297.64","article-title":"Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies","volume":"68","author":"Ballard","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-161265_ref38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00415-009-5000-2","article-title":"Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer\u2019s disease","volume":"256","author":"Chalmers","year":"2009","journal-title":"J Neurol"},{"key":"10.3233\/JAD-161265_ref39","doi-asserted-by":"crossref","first-page":"636","DOI":"10.7164\/antibiotics.31.636","article-title":"Amastatin, an inhibitor of aminopeptidase A, produced by actinomycetes","volume":"31","author":"Aoyagi","year":"1978","journal-title":"J Antibiot (Tokyo)"},{"key":"10.3233\/JAD-161265_ref40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/2051-5960-1-56","article-title":"N-truncated Abeta starting with position four: Early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody","volume":"1","author":"Antonios","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-161265_ref41","doi-asserted-by":"crossref","first-page":"10956","DOI":"10.1021\/ja503535m","article-title":"The N-terminal region of amyloid beta controls the aggregation rate and fibril stability at low pH through a gain of function mechanism","volume":"136","author":"Brannstrom","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.3233\/JAD-161265_ref42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1570159X11311020007","article-title":"ACE2-Ang-(1-7)-Mas axis in brain: A potential target for prevention and treatment of ischemic stroke","volume":"11","author":"Jiang","year":"2013","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-161265_ref43","doi-asserted-by":"crossref","first-page":"R804","DOI":"10.1152\/ajpregu.00222.2010","article-title":"ACE2\/ANG-(1-7)\/Mas pathway in the brain: The axis of good","volume":"300","author":"Xu","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.3233\/JAD-161265_ref44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer\u2019s disease in association with increasing amyloid-beta and tau pathology","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-161265_ref45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mcn.2005.03.012","article-title":"Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas","volume":"29","author":"Hellner","year":"2005","journal-title":"Mol Cell Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-161265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:40Z","timestamp":1777370620000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-161265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":45,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-161265","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]}}}